NOVAVAX INC Revenue
NOVAVAX INC (NVAX) reported Revenue of $56.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-06
- NOVAVAX INC revenues for the quarter ending 2026-06-30 was $56.70M, a 76.30% decline year-over-year.
- NOVAVAX INC revenues for the quarter ending 2026-03-31 was $139.51M, a 79.07% decline year-over-year.
- NOVAVAX INC revenues for the quarter ending 2025-12-31 was $147.14M, a 66.61% increase year-over-year.
- NOVAVAX INC revenues for the quarter ending 2025-09-30 was $70.44M, a 16.64% decline year-over-year.
- NOVAVAX INC revenues for fiscal 2025 was $1.12B, a 64.69% increase from fiscal 2024.
- NOVAVAX INC revenues for fiscal 2024 was $682.16M, a 30.65% decline from fiscal 2023.
- NOVAVAX INC revenues for fiscal 2023 was $983.71M, a 50.36% decline from fiscal 2022.
- NOVAVAX INC revenues for fiscal 2022 was $1.98B, a 72.89% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $56.70M 10-Q · filed 2026-08-06 | $196.21M 10-Q · filed 2026-08-06 | $343.35M derived: sum of 3 quarters · filed 2026-08-06 | $413.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $139.51M 10-Q · filed 2026-05-06 | $286.65M derived: sum of 2 quarters · filed 2026-05-06 | $357.10M derived: sum of 3 quarters · filed 2026-05-06 | $596.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $147.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $217.58M derived: sum of 2 quarters · filed 2026-02-26 | $456.82M derived: sum of 3 quarters · filed 2026-08-06 | $1.12B 10-K · filed 2026-02-26 |
| 2025-09-30 | $70.44M 10-Q · filed 2025-11-06 | $309.69M derived: sum of 2 quarters · filed 2026-08-06 | $976.34M 10-Q · filed 2025-11-06 | $1.06B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $239.24M 10-Q · filed 2026-08-06 | $905.89M 10-Q · filed 2026-08-06 | $994.21M derived: sum of 3 quarters · filed 2026-08-06 | $1.08B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $666.65M 10-Q · filed 2026-05-06 | $754.97M derived: sum of 2 quarters · filed 2026-05-06 | $839.48M derived: sum of 3 quarters · filed 2026-05-06 | $1.25B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $88.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $172.82M derived: sum of 2 quarters · filed 2026-02-26 | $588.31M derived: sum of 3 quarters · filed 2026-02-26 | $682.16M 10-K · filed 2026-02-26 |
| 2024-09-30 | $84.51M 10-Q · filed 2025-11-06 | $500.00M derived: sum of 2 quarters · filed 2025-11-06 | $593.85M 10-Q · filed 2025-11-06 | $885.19M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $415.48M 10-Q · filed 2025-08-06 | $509.34M 10-Q · filed 2025-08-06 | $800.68M derived: sum of 3 quarters · filed 2026-02-26 | $987.67M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $93.86M 10-Q · filed 2025-05-08 | $385.20M derived: sum of 2 quarters · filed 2026-02-26 | $572.18M derived: sum of 3 quarters · filed 2026-02-26 | $996.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $291.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $478.33M derived: sum of 2 quarters · filed 2026-02-26 | $902.75M derived: sum of 3 quarters · filed 2026-02-26 | $983.71M 10-K · filed 2026-02-26 |
| 2023-09-30 | $186.99M 10-Q · filed 2024-11-12 | $611.41M derived: sum of 2 quarters · filed 2024-11-12 | $692.36M 10-Q · filed 2024-11-12 | $1.05B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $424.43M 10-Q · filed 2024-08-08 | $505.38M 10-Q · filed 2024-08-08 | $862.78M derived: sum of 3 quarters · filed 2025-02-27 | $1.60B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $80.95M 10-Q · filed 2024-05-10 | $438.35M derived: sum of 2 quarters · filed 2025-02-27 | $1.17B derived: sum of 3 quarters · filed 2025-02-27 | $1.36B derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $357.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.09B derived: sum of 2 quarters · filed 2025-02-27 | $1.28B derived: sum of 3 quarters · filed 2025-02-27 | $1.98B 10-K · filed 2025-02-27 |
| 2022-09-30 | $734.58M 10-Q · filed 2023-11-09 | $920.50M derived: sum of 2 quarters · filed 2023-11-09 | $1.62B 10-Q · filed 2023-11-09 | $1.85B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $185.93M 10-Q · filed 2023-08-08 | $889.90M 10-Q · filed 2023-08-08 | $1.11B derived: sum of 3 quarters · filed 2024-02-28 | $1.29B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $703.97M 10-Q · filed 2023-05-09 | $926.17M derived: sum of 2 quarters · filed 2024-02-28 | $1.11B derived: sum of 3 quarters · filed 2024-02-28 | $1.40B derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $222.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $401.04M derived: sum of 2 quarters · filed 2024-02-28 | $699.06M derived: sum of 3 quarters · filed 2024-02-28 | $1.15B 10-K · filed 2024-02-28 |
| 2021-09-30 | $178.84M 10-Q · filed 2022-11-09 | $476.86M derived: sum of 2 quarters · filed 2022-11-09 | $924.09M 10-Q · filed 2022-11-09 | $1.20B derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $298.02M 10-Q · filed 2022-08-09 | $745.25M 10-Q · filed 2022-08-09 | $1.02B derived: sum of 3 quarters · filed 2023-02-28 | $1.18B derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $447.23M 10-Q · filed 2022-05-10 | $726.89M derived: sum of 2 quarters · filed 2023-02-28 | $883.91M derived: sum of 3 quarters · filed 2023-02-28 | $919.45M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $279.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $436.68M derived: sum of 2 quarters · filed 2023-02-28 | $472.22M derived: sum of 3 quarters · filed 2023-02-28 | $475.60M 10-K · filed 2023-02-28 |
| 2020-09-30 | $157.02M 10-Q · filed 2021-11-05 | $192.56M derived: sum of 2 quarters · filed 2021-11-05 | $195.94M 10-Q · filed 2021-11-05 | $204.75M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $35.54M 10-Q · filed 2021-08-05 | $38.91M 10-Q · filed 2021-08-05 | $47.73M derived: sum of 3 quarters · filed 2021-08-05 | $50.24M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $3.38M 10-Q · filed 2021-05-10 | $12.19M derived: sum of 2 quarters · filed 2021-05-10 | $14.70M derived: sum of 3 quarters · filed 2021-05-10 | $18.06M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $8.82M 10-K · filed 2020-03-11 | $11.32M derived: sum of 2 quarters · filed 2020-11-10 | $14.68M derived: sum of 3 quarters · filed 2020-11-10 | $18.66M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.51M 10-Q · filed 2020-11-10 | $5.86M derived: sum of 2 quarters · filed 2020-11-10 | $9.85M 10-Q · filed 2020-11-10 | $15.97M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $3.36M 10-Q · filed 2020-08-10 | $7.34M 10-Q · filed 2020-08-10 | $13.47M derived: sum of 3 quarters · filed 2020-08-10 | $21.20M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $3.98M 10-Q · filed 2020-05-11 | $10.11M derived: sum of 2 quarters · filed 2020-05-11 | $17.84M derived: sum of 3 quarters · filed 2020-05-11 | $28.62M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $6.13M 10-K · filed 2020-03-11 | $13.86M derived: sum of 2 quarters · filed 2020-03-11 | $24.64M derived: sum of 3 quarters · filed 2020-03-11 | $34.29M 10-K · filed 2021-03-01 |
| 2018-09-30 | $7.74M 10-K · filed 2020-03-11 | $18.51M derived: sum of 2 quarters · filed 2020-03-11 | $28.16M 10-Q · filed 2019-11-07 | $38.57M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-06-30 | $10.77M 10-K · filed 2020-03-11 | $20.43M 10-Q · filed 2019-08-07 | $30.84M derived: sum of 3 quarters · filed 2020-03-11 | $39.19M derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-03-31 | $9.65M 10-K · filed 2020-03-11 | $20.07M derived: sum of 2 quarters · filed 2020-03-11 | $28.42M derived: sum of 3 quarters · filed 2020-03-11 | $35.15M derived: sum of 4 quarters · filed 2020-03-11 |
| 2017-12-31 | $10.41M 10-K · filed 2019-03-18 | $18.76M derived: sum of 2 quarters · filed 2019-03-18 | $25.50M derived: sum of 3 quarters · filed 2019-03-18 | $31.18M 10-K · filed 2020-03-11 |
| 2017-09-30 | $8.35M 10-K · filed 2019-03-18 | $15.08M derived: sum of 2 quarters · filed 2019-03-18 | $20.76M 10-Q · filed 2018-11-07 | $26.16M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $6.73M 10-K · filed 2019-03-18 | $12.41M 10-Q · filed 2018-08-08 | $17.81M derived: sum of 3 quarters · filed 2019-03-18 | $21.04M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $5.68M 10-K · filed 2019-03-18 | $11.08M derived: sum of 2 quarters · filed 2019-03-18 | $14.31M derived: sum of 3 quarters · filed 2019-03-18 | $16.82M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $5.40M 10-K · filed 2018-03-14 | $8.63M derived: sum of 2 quarters · filed 2018-03-14 | $11.13M derived: sum of 3 quarters · filed 2018-03-14 | $15.35M 10-K · filed 2019-03-18 |
| 2016-09-30 | $3.23M 10-K · filed 2018-03-14 | $5.74M derived: sum of 2 quarters · filed 2018-03-14 | $9.95M 10-Q · filed 2017-11-07 | $15.81M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $2.50M 10-K · filed 2018-03-14 | $6.72M 10-Q · filed 2017-08-08 | $12.58M derived: sum of 3 quarters · filed 2018-03-14 | $19.10M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $4.22M 10-K · filed 2018-03-14 | $10.07M derived: sum of 2 quarters · filed 2018-03-14 | $16.60M derived: sum of 3 quarters · filed 2018-03-14 | $30.59M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $5.85M 10-K · filed 2017-02-27 | $12.38M derived: sum of 2 quarters · filed 2017-02-27 | $26.37M derived: sum of 3 quarters · filed 2017-02-27 | $36.25M 10-K · filed 2018-03-14 |
| 2015-09-30 | $6.53M 10-K · filed 2017-02-27 | $20.52M derived: sum of 2 quarters · filed 2017-02-27 | $30.40M 10-Q · filed 2016-11-09 | $37.12M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $14.00M 10-K · filed 2017-02-27 | $23.87M 10-Q · filed 2016-08-09 | $30.60M derived: sum of 3 quarters · filed 2017-02-27 | $38.81M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $9.88M 10-K · filed 2017-02-27 | $16.60M derived: sum of 2 quarters · filed 2017-02-27 | $24.82M derived: sum of 3 quarters · filed 2017-02-27 | $33.07M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $6.72M 10-K · filed 2016-02-29 | $14.94M derived: sum of 2 quarters · filed 2016-02-29 | $23.20M derived: sum of 3 quarters · filed 2016-02-29 | $30.66M 10-K · filed 2017-02-27 |
| 2014-09-30 | $8.21M 10-K · filed 2016-02-29 | $16.47M derived: sum of 2 quarters · filed 2016-02-29 | $23.93M 10-Q · filed 2015-11-09 | $32.68M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $8.26M 10-K · filed 2016-02-29 | $15.72M 10-Q · filed 2015-08-10 | $24.47M derived: sum of 3 quarters · filed 2016-02-29 | $29.27M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $7.46M 10-K · filed 2016-02-29 | $16.21M derived: sum of 2 quarters · filed 2016-02-29 | $21.01M derived: sum of 3 quarters · filed 2016-02-29 | $24.54M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $8.75M 10-K · filed 2015-02-27 | $13.55M derived: sum of 2 quarters · filed 2015-02-27 | $17.08M derived: sum of 3 quarters · filed 2015-02-27 | $20.91M 10-K · filed 2016-02-29 |
| 2013-09-30 | $4.80M 10-K · filed 2015-02-27 | $8.33M derived: sum of 2 quarters · filed 2015-02-27 | $12.17M 10-Q · filed 2014-11-06 | $16.73M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $3.53M 10-K · filed 2015-02-27 | $7.37M 10-Q · filed 2014-08-07 | $11.93M derived: sum of 3 quarters · filed 2015-02-27 | $17.70M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $3.83M 10-K · filed 2015-02-27 | $8.40M derived: sum of 2 quarters · filed 2015-02-27 | $14.16M derived: sum of 3 quarters · filed 2015-02-27 | $21.27M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $4.57M 10-K · filed 2014-03-12 | $10.33M derived: sum of 2 quarters · filed 2014-03-12 | $17.43M derived: sum of 3 quarters · filed 2014-03-12 | $22.08M 10-K · filed 2015-02-27 |
| 2012-09-30 | $5.76M 10-K · filed 2014-03-12 | $12.87M derived: sum of 2 quarters · filed 2014-03-12 | $17.51M 10-Q · filed 2013-11-12 | $23.36M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $7.10M 10-K · filed 2013-03-12 | $11.74M 10-Q · filed 2013-08-08 | $17.59M derived: sum of 3 quarters · filed 2014-03-12 | $22.60M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $4.64M 10-K · filed 2014-03-12 | $10.49M derived: sum of 2 quarters · filed 2014-03-12 | $15.49M derived: sum of 3 quarters · filed 2014-03-12 | $18.50M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $5.84M 10-K · filed 2013-03-12 | $10.85M derived: sum of 2 quarters · filed 2013-03-12 | $13.85M derived: sum of 3 quarters · filed 2013-03-12 | $14.69M 10-K · filed 2014-03-12 |
| 2011-09-30 | $5.01M 10-K · filed 2013-03-12 | $8.01M derived: sum of 2 quarters · filed 2013-03-12 | $8.84M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $3.00M 10-K · filed 2013-03-12 | $3.83M derived: sum of 2 quarters · filed 2013-03-12 | ||
| 2011-03-31 | $834.00K 10-K · filed 2013-03-12 | |||
| 2010-12-31 | $343.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |